At the news
? NEUTRALIMPACT 2/10 CLUSTER filed Jul 8, 2026 at 18:49 ET
Two C-suite insiders at Contineum Therapeutics (CEO and CSO) sold a combined $132K in open-market sales over a 7-day window. The total value represents just 0.024% of the company's $544M market cap, making this a trivial, routine cluster with no material signal.
- CEO Carmine Stengone sold 2,500 shares at $16.00 for $40K on 2026-07-08
- CSO Daniel Lorrain sold 5,900 shares at $15.67 for $92K on 2026-07-01
- Total insider sales of $132K represent ~0.024% of CTNM's $544M market cap
- CEO also exercised non-cash derivative transactions on the same day (no economic impact)
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access